To validate the CD4/CD8 T‐cell enhanced effector function, as suggested by the in silico analysis, we analysed the expression of IFNγ, perforin and granzyme b in the tumour‐infiltrating lymphocyte populations by flow cytometry. The gene discussed is CD8A; the disease is neoplasm.